SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending with community members citing its privacy features and potential as a hedge against Bitcoin. Some are drawing comparisons to Bitcoin's early days and anticipating a significant price increase. The conversation includes discussion of Zcash's upcoming anniversary and potential for new highs.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp. - Warrants (27/02/2029)

Critical Metals Corp. warrants ($CRMLW) are trending as traders discuss potential for significant gains relative to the common stock, especially with resource estimate updates and possible short squeezes. Community members highlight the warrants' trading flexibility during extended hours and their potential for higher percentage gains compared to the common stock ($CRML). Some are also pointing to the EU waking up to critical metals, which may be a catalyst.

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by Ronald Hafner, Eric Konofal, and Alexander Zwyer on June 10, 2015 and is headquartered in Zurich, Switzerland.

NewcelX Ltd.

NCEL is trending due to its recent merger with Kadimastem and subsequent ticker change, although some investors express concern over the reverse split and its impact on share value. Community members are actively discussing the potential for a short squeeze and the stock's future price, while also referencing technical indicators and potential broker issues related to the split. The merger's strategic implications and the combined company's prospects are also being debated.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending amid increased discussion of potential collaborations with ExxonMobil on carbon capture technology for data centers, sparked by a recent conference call. The community is focused on interpreting statements made during the call and the potential impact of any partnership on FCEL's future prospects, especially when compared to sector peers. Interest is also fueled by the rising demand for clean energy solutions to power AI.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending due to a recent volume spike and increased attention on its micro float. Community members are discussing the potential for a significant price increase, drawing comparisons to other low-float stocks that have experienced parabolic runs. The stock's recent price action and the possibility of a squeeze are also key talking points.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as traders assess market volatility amid mixed signals, including concerns about potential pullbacks and upcoming earnings reports from major tech companies. Community discussions revolve around hedging strategies and interpreting market indicators, with some anticipating a possible market correction or a volatility spike due to geopolitical tensions or economic uncertainty. The potential impact of upcoming economic data and policy decisions on market stability is also a key focus.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending due to the appointment of a new CFO from Johnson & Johnson, sparking optimism about the company's future financial strategies. Community members are actively discussing the potential impact on the company's valuation and long-term prospects, especially with upcoming earnings and existing discussions of Medicare coverage for XPHOZAH.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as investors anticipate earnings, with community discussions focused on the company's growth potential and valuation. Some are drawing comparisons to other tech giants like Nvidia and Meta, while others highlight Palantir's integration with military applications and potential for long-term contracts. Anticipation is building for a potential stock split, though opinions vary regarding a possible post-earnings pullback.

Propy is a decentralized real-estate market place backed by superior blockchain infrastructure to facilitate real-time unified transaction in order to reduce fraud and redundancy. Propy is the world’s first international real-estate marketplace.

Propy

Propy ($PRO) is trending as traders discuss recent price fluctuations and potential for future growth. Community members are actively debating entry and exit points, with some expressing frustration over volatility, while others highlight Propy's potential as a Real World Asset (RWA) project on the Ethereum blockchain and its association with real estate transactions. The conversation also includes speculation about market manipulation and possible upcoming news catalysts.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Recent community discussion around MNKD centers on Oppenheimer's raised price target and speculation regarding a potential deal with Dexcom and pediatric approval for Afrezza. Increased trading volume has some investors suggesting a possible short squeeze. Others express concern about the company's performance and CEO, citing past failures and the need for new catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Baldwin Group Q3 2025 Market Pulse: A Disciplined Market Emerges

The Baldwin Group today released its Q3 2025 Market Pulse, a pricing trend analysis that blends observed rate movement with changes in exposure and client buying behavior to capture real-world...

Primerica (PRI) Expected to Beat Earnings Estimates: Should You Buy?

Primerica (PRI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Baldwin Insurance Group (BWIN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

The Baldwin Insurance Group (BWIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VOYA or BWIN: Which Is the Better Value Stock Right Now?

VOYA vs. BWIN: Which Stock Is the Better Value Option?

LNC vs. BWIN: Which Stock Is the Better Value Option?

New Strong Sell Stocks for September 10th

ALSN, AU and BWIN have been added to the Zacks Rank #5 (Strong Sell) List on September 10, 2025.

New Strong Sell Stocks for September 2nd

NWS, BWIN and HMC have been added to the Zacks Rank #5 (Strong Sell) List on September 2, 2025.

Brighthouse Financial Trades Below 50-Day SMA: How to Play the Stock?

BHF boosts insurance and annuity sales with new products, but rising expenses and debt weigh on margins.

Implied Volatility Surging for Baldwin Insurance Stock Options

Investors need to pay close attention to BWIN stock based on the movements in the options market lately.

Baldwin Insurance Group, Inc. engages in the provision of insurance services. It operates through the following segments: Insurance Advisory Solutions, Underwriting, Capacity & Technology Solutions, and Mainstreet Insurance Solutions. The Insurance Advisory Solutions segment provides private risk management, commercial risk management, and employee benefits solutions for mid-to-large size businesses and high net worth individuals and families. The Underwriting, Capacity & Technology Solutions segment represents a wholesale co-brokerage platform that delivers specialty insurers, professionals, individuals, and niche industry businesses expanded access to exclusive specialty markets, capabilities, and programs requiring complex underwriting and placement. The Mainstreet segment offers personal insurance, commercial insurance, and life and health solutions to individuals and businesses in their communities. The Medicare segment provides consultation for government assistance programs and solutions, including traditional Medicare and Medicare Advantage, to seniors and Medicare-eligible individuals through a network of agents. The company was founded by Elizabeth H. Krystyn, Laura R. Sherman, and Lowry L. Baldwin in 2011 and is headquartered in Tampa, FL.

The Baldwin Insurance Group Inc. - Ordinary Shares - Class A

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$22.10
Prev Close	$21.49
Open	$21.36
Dividend Yield	0.00%
50-Day Moving Average	$28.40
Beta	1.09
Avg. Volume	798,481.29
PE Ratio	-76.87

52-Week High	$50.46
52-Week Low	$21.26
Market Capitalization	$1.58B
EPS (Annual)	-$0.3864
Price to Book	2.50
Revenue Per Employee	$337,472.55
Enterprise Value/EBITDA	N/A

BWIN
The Baldwin Insurance Group Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BWIN News

BWINThe Baldwin Insurance Group Inc. - Ordinary Shares - Class A